Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$655K Buy
19,839
+50
+0.3% +$1.53K 0.01% 871
2014
Q4
$529K Buy
19,789
+100
+0.5% +$2.58K 0.01% 921
2014
Q3
$479K Sell
19,689
-200
-1% -$5.05K 0.01% 846
2014
Q2
$504K Buy
19,889
+280
+1% +$6.54K 0.01% 846
2014
Q1
$422K Buy
19,609
+8,795
+81% +$190K 0.01% 911
2013
Q4
$242K Buy
+10,814
New +$238K ﹤0.01% 1026
2013
Q3
Sell
-23,798
Closed -$459K 1093
2013
Q2
$459K Buy
+23,798
New +$497K 0.01% 794

Other funds holding HOLX

Baird's HOLX Position: Q1 2015 in Review

Baird increased its Hologic (HOLX) stake by 0.25% in Q1 2015, buying an estimated $1.53K and bringing the position to 19,839 shares worth $655K. The position accounts for 0.01% of the portfolio, ranked #871.

Baird first reported a position in HOLX in Q2 2013 and has held it in 7 quarters since. 393 funds tracked by Wall St. Rank hold HOLX as of Q1 2015.

  • Baird held 19,839 shares of Hologic worth $655K as of Q1 2015.
  • Baird bought 50 Hologic shares in Q1 2015, an estimated $1.53K.
  • Hologic made up 0.01% of Baird's portfolio in Q1 2015, its #871 holding.
  • Baird first reported a position in Hologic in Q2 2013 and has held it in 7 quarters since.
  • 393 funds tracked by Wall St. Rank held Hologic as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.